TriangleNCT01018979 · OUTCOME
Number of Patients Who Achieved Mobilization Success of Hematopoietic Stem Cells in Patients With Multiple Myeloma (MM), Non-Hodgkin Lymphoma (NHL) or Hodgkin Disease (HD).
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- NUMBER
- Unit
- participants
- Interval / dispersion
- Not reported
- Time frame
- 1 week
What was measured
Patients who met the target CD34+ cell collection of ≧2 x 106 cells/kg after two apheresis sessions were classified as achieving mobilization success.
Analysis population: In TG-0054 (2.24 mg/kg) group, A total of 4 patients (2 with MM, 1 with NHL, and 1 with HD) underwent apheresis procedure. In TG-0054 (3.14 mg/kg) group, A total of 3 patients (1 with MM and 2 with NHL) underwent apheresis procedure.
Groups in this outcome
TG-0054 (2.24 mg/kg)
TG-0054: 2.24 mg/kg TG-0054 administrated via 15-min IV infusion(allow a maximum of six leukapheresis sessions)
TG-0054 (3.14 mg/kg)
TG-0054: 3.14 mg/kg TG-0054 administrated via 15-min IV infusion(allow a maximum of six leukapheresis sessions)
| Group | Source count |
|---|---|
| TG-0054 (2.24 mg/kg) | 4 |
| TG-0054 (3.14 mg/kg) | 3 |
Reported measurements
MM
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| TG-0054 (2.24 mg/kg) | 1 | Not reported | Not reported | Not reported | Not reported |
| TG-0054 (3.14 mg/kg) | 1 | Not reported | Not reported | Not reported | Not reported |
NHL
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| TG-0054 (2.24 mg/kg) | 1 | Not reported | Not reported | Not reported | Not reported |
| TG-0054 (3.14 mg/kg) | 0 | Not reported | Not reported | Not reported | Not reported |
HD
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| TG-0054 (2.24 mg/kg) | 0 | Not reported | Not reported | Not reported | Not reported |
| TG-0054 (3.14 mg/kg) | 0 | Not reported | Not reported | Not reported | Not reported |
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- value
- 1
- group Id
- OG001
- value
- 1
- title
- MM
- categories
- measurements
- group Id
- OG000
- value
- 1
- group Id
- OG001
- value
- 0
- title
- NHL
- categories
- measurements
- group Id
- OG000
- value
- 0
- group Id
- OG001
- value
- 0
- title
- HD
- denoms
- counts
- group Id
- OG000
- value
- 4
- group Id
- OG001
- value
- 3
- units
- Participants
- description
- Patients who met the target CD34+ cell collection of ≧2 x 106 cells/kg after two apheresis sessions were classified as achieving mobilization success.
- groups
- description
- TG-0054: 2.24 mg/kg TG-0054 administrated via 15-min IV infusion(allow a maximum of six leukapheresis sessions)
- id
- OG000
- title
- TG-0054 (2.24 mg/kg)
- description
- TG-0054: 3.14 mg/kg TG-0054 administrated via 15-min IV infusion(allow a maximum of six leukapheresis sessions)
- id
- OG001
- title
- TG-0054 (3.14 mg/kg)
- param Type
- NUMBER
- population Description
- In TG-0054 (2.24 mg/kg) group, A total of 4 patients (2 with MM, 1 with NHL, and 1 with HD) underwent apheresis procedure. In TG-0054 (3.14 mg/kg) group, A total of 3 patients (1 with MM and 2 with NHL) underwent apheresis procedure.
- reporting Status
- POSTED
- time Frame
- 1 week
- title
- Number of Patients Who Achieved Mobilization Success of Hematopoietic Stem Cells in Patients With Multiple Myeloma (MM), Non-Hodgkin Lymphoma (NHL) or Hodgkin Disease (HD).
- type
- PRIMARY
- unit Of Measure
- participants
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice